Evidence mounts for the efficacy of radioimmuno... [J Clin Oncol. 2008] - PubMed

Save items

loading

Click here to read article using PubReader

Related citations in PubMed

Review Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. [N Engl J Med. 2008]
Review Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.
Cheson BD, Leonard JP. N Engl J Med. 2008 Aug 7; 359(6):613-26.
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. [J Clin Oncol. 2008]
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Morschhauser F, Radford J, Van Hoof A, Vitolo U, Soubeyran P, Tilly H, Huijgens PC, Kolstad A, d'Amore F, Gonzalez Diaz M, et al. J Clin Oncol. 2008 Nov 10; 26(32):5156-64. Epub 2008 Oct 14.
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation. [J Clin Oncol. 2008]
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
Devizzi L, Guidetti A, Tarella C, Magni M, Matteucci P, Seregni E, Chiesa C, Bombardieri E, Di Nicola M, Carlo-Stella C, et al. J Clin Oncol. 2008 Nov 10; 26(32):5175-82. Epub 2008 Oct 14.
Review Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma. [Int J Radiat Oncol Biol Phys. ...]
Review Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
Hernandez MC, Knox SJ. Int J Radiat Oncol Biol Phys. 2004 Aug 1; 59(5):1274-87.
Review Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. [Clin Adv Hematol Oncol. 2004]
Review Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ, Gowda A, Czuczman MS. Clin Adv Hematol Oncol. 2004 Sep; 2(9):606-18.

See reviews... See all...

Cited by 4 PubMed Central articles

Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma. [Cancer Manag Res. 2009]
Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.
Emmanouilides C. Cancer Manag Res. 2009 Oct 21; 1:131-6. Epub 2009 Oct 21.
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants. [Bioconjug Chem. 2010]
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
Wilbur DS, Park SI, Chyan MK, Wan F, Hamlin DK, Shenoi J, Lin Y, Wilbur SM, Buchegger F, Pantelias A, et al. Bioconjug Chem. 2010 Jul 21; 21(7):1225-38.
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides. [Cancer. 2010]
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
Sharkey RM, Karacay H, Goldenberg DM. Cancer. 2010 Feb 15; 116(4 Suppl):1134-45.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
J Clin Oncol. 2008 Nov 10 ;26(32):5147-50. doi: 10.1200/JCO.2008.18.5447. Epub 2008 Oct 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.

Comment in

Comment on

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information